Literature DB >> 9499093

Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16.

A Schulze1, B Mannhardt, K Zerfass-Thome, W Zwerschke, P Jansen-Dürr.   

Abstract

To develop an experimental model for E7-mediated anchorage-independent growth, we studied the ability of E7-expressing NIH 3T3 subclones to enter S phase when they were cultured in suspension. We found that expression of E7 prevents the inhibition of cyclin E-associated kinase and also triggers activation of cyclin A gene expression in suspension cells. A point mutation in the amino terminus of E7 prevented E7-driven rescue of cyclin E-associated kinase activity in suspension cells; however, cells with this mutation retained some ability to activate cyclin A gene expression and promote S-phase entry. Activation of cyclin A gene expression by E7 was correlated with an increased binding of free E2F to a regulatory element in the cyclin A promoter which mediates both repression of cyclin A upon loss of adhesion and its reactivation by E7. Surprisingly, expression of E7 led to a nuclear accumulation of one species of free E2F, namely, an E2F-4-DP-1 heterodimer, that is exclusively cytoplasmic in the absence of E7. Taken together, the data reported here indicate that several different E7-dependent changes of cellular-growth-regulating pathways can cooperate to allow adhesion-independent entry into S phase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499093      PMCID: PMC109532          DOI: 10.1128/JVI.72.3.2323-2334.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.

Authors:  M N Ruesch; L A Laimins
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.

Authors:  D Spitkovsky; A Schulze; B Boye; P Jansen-Dürr
Journal:  Cell Growth Differ       Date:  1997-06

3.  The subcellular localization of E2F-4 is cell-cycle dependent.

Authors:  G J Lindeman; S Gaubatz; D M Livingston; D Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.

Authors:  J O Funk; S Waga; J B Harry; E Espling; B Stillman; D A Galloway
Journal:  Genes Dev       Date:  1997-08-15       Impact factor: 11.361

5.  The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

Authors:  D L Jones; R M Alani; K Münger
Journal:  Genes Dev       Date:  1997-08-15       Impact factor: 11.361

6.  Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.

Authors:  G W Demers; S A Foster; C L Halbert; D A Galloway
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines.

Authors:  J Lukas; M Pagano; Z Staskova; G Draetta; J Bartek
Journal:  Oncogene       Date:  1994-03       Impact factor: 9.867

8.  Structure and cell cycle-regulated transcription of the human cyclin A gene.

Authors:  B Henglein; X Chenivesse; J Wang; D Eick; C Bréchot
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  D-type cyclin-dependent kinase activity in mammalian cells.

Authors:  H Matsushime; D E Quelle; S A Shurtleff; M Shibuya; C J Sherr; J Y Kato
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.

Authors:  J Lukas; H Müller; J Bartkova; D Spitkovsky; A A Kjerulff; P Jansen-Dürr; M Strauss; J Bartek
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

View more
  13 in total

1.  Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

Authors:  A M Helt; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.

Authors:  C Swanton; N Jones
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

3.  Distinct effects of mitogens and the actin cytoskeleton on CREB and pocket protein phosphorylation control the extent and timing of cyclin A promoter activity.

Authors:  M E Bottazzi; M Buzzai; X Zhu; C Desdouets; C Bréchot; R K Assoian
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 4.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

5.  Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells.

Authors:  S Tang; M Tao; J P McCoy; Z M Zheng
Journal:  Oncogene       Date:  2006-03-30       Impact factor: 9.867

Review 6.  Effect of transforming viruses on molecular mechanisms associated with cancer.

Authors:  Tajhal Dayaram; Susan J Marriott
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

7.  Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function.

Authors:  Amy Baldwin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 8.  Biology of human papillomaviruses.

Authors:  H R McMurray; D Nguyen; T F Westbrook; D J McAnce
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

9.  E7 abolishes raf-induced arrest via mislocalization of p21(Cip1).

Authors:  Thomas F Westbrook; Don X Nguyen; Barry R Thrash; Dennis J McCance
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Human papillomavirus type 16 E7 oncoprotein associates with E2F6.

Authors:  Margaret E McLaughlin-Drubin; Kyung-Won Huh; Karl Münger
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.